CD80 and breast cancer: Several of these molecules have been previously implicated in BC development and progression, including CD28 (71), CD80 (72), VTCN1 (73), IDO1 (74), PDCDLG2 (75), TIGIT (76), PD-1, and PD-L1 (77).